A substituted pyrolidine compound 2-[(s)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide
PK140595AUndetermined Publication Date: 2010-04-08THERAVANCE INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200400432
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-04-08
Abstract
This invention is directed compound of formula I: Wherein R1 -R5 and a-e are as defined in the specification; The invention also directed to pharmaceutical composition containing such compound.
Need to check novelty before this filing date? Find Prior Art